The Kano State Drugs and Medical Consumables Supply Agency (DMCSA) has increased its working capital to ₦377,033,845 after clearing an inherited debt of ₦102,238,600 between 2023 and 2025.
The Director-General of the agency, Pharmacist Gali Sule, disclosed this in an interview with ‘The Historica Nigeria’ as part of the agency’s end-of-year review for 2025.
According to him, the debt clearance marks a major milestone, restoring the agency’s credibility and operational efficiency since December 2023. He explained that the DMCSA has almost completed the settlement of outstanding liabilities owed to pharmaceutical companies responsible for supplying essential drugs to Kano State hospitals.
“This debt clearance was achieved through the monthly Drug Revolving Fund accountability sessions introduced by the current leadership. These meetings help identify challenges, review progress, and strengthen transparency,” he said.
Read Also:
Kano Govt Approves N233 Million for Procurement of Laboratory Equipment for DMCSA
Nigerian Army Suspends Retirements Amid Nationwide Security Emergency
Governor Yusuf Nominated for National Award on Visionary Leadership
Pharmacist Sule noted that the strengthened reform process has improved the agency’s reputation among development partners and suppliers. “You see, the negative debt we inherited from the past administration weakened our operations. But through close supervision and collaboration among all key units — including the Drugs Management System, Procurement, and Financial Operations — we were able to recover and settle over ₦1 billion in old debts,” he added.
He commended Governor Abba Kabir Yusuf’s administration for its tireless support, revealing that the state government now releases ₦40 million daily to support hospitals across Kano, compared to ₦10 million previously. “This increase covers the free Maternal, Newborn and Child Health (MNCH) programme as well as drug supplies to correctional centres in the state,” he stated.
The DG further announced that the agency has expanded its logistics capacity with new vehicles to enhance drug distribution across zonal stores and health facilities. “Before now, we relied on commercial logistics, which sometimes diverted drugs to locations outside our knowledge,” he revealed.
He explained that the agency currently supplies medicines and consumables to more than 1,200 primary healthcare centres, 46 secondary hospitals, and several tertiary hospitals in Kano State — all at affordable and regulated prices. “Drug access in these facilities is now assured and has increased significantly due to the strengthened Drug Revolving Fund system,” he added.
Pharmacist Sule also disclosed that the state-of-the-art Pharma Grade Warehouse will be commissioned in January 2026 as part of the agency’s achievements from 2023 to date. He confirmed that medicines produced internally by the agency are fully registered by the Pharmaceutical Council of Nigeria (PCN) and NAFDAC, ensuring their safety and authenticity. “These products are genuine, certified, and we will soon begin supplying them to private health centres across the state,” he said.
He assured agency staff that their welfare remains a top priority, describing them as the backbone of DMCSA’s operations. “We will continue ensuring that affordable, genuine medicines remain available in all public health centres without interruption,” he affirmed.
Established in 2009 through an act of the Kano State House of Assembly, the DMCSA supervises the procurement and distribution of drugs and medical consumables to government-owned health facilities across the state.
Pharmacist Gali Sule, who has led the agency since 2023, attributed the agency’s successes to the consistent support of Governor Abba Kabir Yusuf’s administration.